ACTIVE LEARNING TEMPLATES
Medication
STUDENT NA ME _____________________________________
MEDICATION __________________________________________________________________________ REVIEW MODULE CHAPTER ___________
CAT EGO RY CL ASS ______________________________________________________________________
ACTIVE LEARNING TEMPLATE:
PURPOSE OF MEDICATION
Expected Pharmacological Action
Complications
Contraindications/Precautions
Interactions
Medication Administration
Evaluation of Medication Effectiveness
Therapeutic Use
Nursing Interventions
Client Education
Class II antidysrhythmics Beta Blockers (lols)
Blocks beta receptors decreasing the sypathetic
nervous system effects: decreases spontaneous SA
node activity, decreaseing conduction throught the AV
node, decreasing contraction of the heart
Give po with or without food at
consistent times. Assess BP prior to
administration hold if systolic is < 90 or
HR is < 60 and notify provider.
IV use for life threatening
dysrhythmias directly by IV bolus over
1 minute or intermittent infusion over
15-20 minutes
Any antihypertensive increases the risk for hypotension.
Antacisd decrease absorption. Digoxin increases risk for
bradycardia. Hypoglycemic agents increase the risk for
hypoglycemia. Ant-cholinergic may degreas the effects of
beta blockers
Sinus brady, second to thrid degree heart block, pulmonary edema,
mitral or aortic valve disease, cardiogenic shock, PVD, asthma,
chronic respiratory disorders. Use caution with hyperthyroidism, renal
or liever disorders, CVA, DM, hypoglycemia, hx of allergy to stinging
insects
Bradycardia, reduced cardiac output, rebound anginaor MI
if stopped abruptly, peripheral artety insufficiency,
confusion, fatigue, drowsiness
atrial and ventricular tachycardia and
tachycardia caused by exercise or emotion,
hypertension, angina pectoris, decreases
mortality after MI, migraine HA prophyaxisis,
ASsess HR and report <
60BPM. ASsess BP and report
< 90 systolic. ASsess S/S of
heart failure. Do not stop
abruptly. Taper dose over 1-2
weeks. ASsess peripheral
circultory status and CNS effects
controlled atrial and ventricular rate and rhythm decresed
BP, decreased occurence ofangina pectoris, decreased
mortality after MI, decreased occurence of migraine HA,
Teach to monitor HR, hold drug and
report < 60 BPM. Report SOB, edema
and night cough. DO NOT stop taking
abruptly. Report increase in angina or
any new chest pain. Protect
extremities from cold and report any
sensation of cold or numbness to
extremities. Avoid hazardous activites
and report any CNS effects
